What’s New What is the CDER Quality Standards Program? The CDER Quality Standards Program will help promote innovation in pharmaceutical development and manufacturing and streamline the […]

Delivery Method: VIA UPS Reference #: 320-25-13 Product: Drugs Recipient: Recipient Name Mr. Jinyan Wang Recipient Title General Manager Zhejiang Qimei Cosmetics Co., Ltd. No. 518 […]

Delivery Method: VIA UPS Reference #: 320-25-10 Product: Drugs Recipient: Recipient Name Mr. Alexis Wolkowinski Recipient Title President Multaler et Cie SAS 1 Rue Ambroise CroizatArgenteuil95100 […]

[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 10ml, a product promoted for energy and sexual enhancement on […]

[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 20ml, a product promoted for energy and sexual enhancement on […]

[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use  VITAFER-L Gold 500ml, a product promoted for energy and sexual enhancement on […]

On November 8, 2024, the Food and Drug Administration approved obecabtagene autoleucel (Aucatzyl, Autolus Inc.), a CD19-directed genetically modified autologous T cell immunotherapy, for adults with […]

For Immediate Release: November 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

COMMITTEE’S OFFICIAL DESIGNATION Drug Safety and Risk Management Advisory Committee AUTHORITY The Drug Safety and Risk Management Advisory Committee (the Committee) is established under 15 U.S.C. […]